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Background: Eastern equine encephalitis virus (EEEV) is an alphavirus with a case fatality rate estimated to be as
high as 75 % in humans and 90 % in horses. Surviving patients often have long-lasting and severe neurological
sequelae. At present, there is no licensed vaccine or therapeutic for EEEV infection. This study completes the clinical
and pathological analysis of mice infected with a North American strain of EEEV by three different routes: aerosol,
intranasal, and subcutaneous. Such an understanding is imperative for use of the mouse model in vaccine and
antiviral drug development.
Methods: Twelve-week-old female BALB/c mice were infected with EEEV strain FL93-939 by the intranasal, aerosol,
or subcutaneous route. Mice were euthanized 6 hpi through 8 dpi and tissues were harvested for histopathological
and immunohistochemical analysis.
Results: Viral antigen was detected in the olfactory bulb as early as 1–2 dpi in aerosol and intranasal infected mice.
However, histologic lesions in the brain were evident about 24 hours earlier (3 dpi vs 4 dpi), and were more
pronounced following aerosol infection relative to intranasal infection. Following subcutaneous infection, viral
antigen was also detected in the olfactory bulb, though not as routinely or as early. Significant histologic lesions
were not observed until 6 dpi.
Conclusion: These pathologic studies suggest EEEV enters the brain through the olfactory system when mice are
exposed via the intranasal and aerosol routes. In contrast, the histopathologic lesions were delayed in the
subcutaneous group and it appears the virus may utilize both the vascular and olfactory routes to enter the brain
when mice are exposed to EEEV subcutaneously.
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Eastern equine encephalitis viruses (EEEV), genus
Alphavirus in the family Togaviridae, are single-strand,
positive-sense RNA viruses that causes significant mor-
bidity and mortality in infected horses, birds, and
humans [1]. There are four antigenic subtypes of EEEV,
one that circulates in North America and the Caribbean
(NA EEEV), and three that circulate in Central and
South America (formerly SA EEEV, recently redesignated
Madariaga virus (MADV)) [2]. The strains differ in their
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conserved, monophyletic, and temporally related, while
MADV strains are highly divergent, polyphyletic, co-
circulating, and geographically associated [3]. NA EEEV,
which has been associated with epizootics among horses
and humans along the Atlantic and Gulf Coasts as well as
in the Great Lakes Region, results in approximately 5–8
cases of neuroinvasive disease in humans yearly, while
MADV has limited association with human disease, des-
pite evidence of human exposure in endemic areas [4, 5].
NA EEEV is listed as a category B agent by the National
Institute of Allergy and Infectious Diseases (NIAID) due
to its virulence, its potential use as a biological weapon,
and the lack of a licensed vaccine or effective antiviral
treatment for human infections.le is distributed under the terms of the Creative Commons Attribution 4.0
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cephalitis virus, several small animal models have been
used to study NA EEEV pathogenesis, including mice,
hamsters, guinea pigs, and rats [6]. Mice are susceptible
to NA EEEV induced mortality by a variety of routes of
infection, including aerosol, intranasal, and subcutane-
ous in typically an age-dependent manner, with older
mice becoming generally more resistant to infection [6].
However, systematic pathogenesis studies of EEEV infec-
tion in the mouse model are lacking.
Recently, NA EEEV strain FL93-939 was shown to be
virulent in adult mice following peripheral infection [7].
Further, this strain was observed to decrease type I inter-
feron induction in FL93-939-infected mice [7–9]. The
purpose of this study was to characterize the pathogen-
esis of NA EEEV FL93-939 in mice after infection by
one of three important routes: aerosol, intranasal, and
subcutaneous, expecting that the pathogenesis would
differ in a route-dependent manner. In an initial report,
we described the clinical parameters of infection, includ-
ing the effect of infection on body weight, temperature,
and activity, and well as the virus distribution in tissues
over time [10]. Here the histological and immunohisto-
chemical features of infection by each of the three routes
were examined. A complete understanding of the patho-
genesis of NA EEEV and how it differs based on route of
infection is an important step in the development of
antiviral therapeutics.
Results
Five mice from each time point were euthanized and
perfused with 10 % NBF and routine tissues were col-
lected for histologic and immunohistochemical analysis.
There were many similarities in the pathogenesis of
EEEV in the IN and AE studies and significant differ-
ences identified in the SC study, emphasizing the im-
portance of evaluating various challenge routes when
developing medical countermeasures.
Intranasal challenge
Key immunohistochemical findings and histologic
lesions from the IN study are summarized in Tables 1
and 2, respectively. In the IN study, viral antigen was
first detected in the nasal cavity (Fig. 1a), olfactory epi-
thelium and lamina propria (Fig. 1b, arrow), and odonto-
blasts of a tooth as early as 1 dpi. However, no histologic
lesions were noted at these sites at this time. By 2 dpi,
viral antigen was observed more frequently in the nasal
cavity (Fig. 1c), specifically in the olfactory epithelium
and underlying lamina propria (Fig. 1c, arrows) and not
within the respiratory epithelium (Fig. 1c, arrow head),
as well as in the olfactory bulb (Fig. 1d), and in low
numbers of neurons in the cerebrum, primarily in the
piriform cortex. In some sites where antigen waspresent, single cell death was noted, characterized by
pyknosis and eosinophilic cellular and karyorrhectic deb-
ris without inflammation, suggestive of apoptosis. Both
the immunohistochemical and histologic findings at 3
dpi were similar to those seen at 2 dpi, with viral antigen
present in the nasal cavity, olfactory bulb, and cerebrum,
accompanied by single cell death in a small number of
cells in the areas where antigen was present. At both 4
and 5 dpi; however, viral antigen was noted multifocally
in the nasal cavity, and teeth, as well as diffusely
throughout the olfactory bulb, frontal cortex, midbrain
(Fig. 1e), cerebellum, brain stem, and spinal cord. Add-
itionally, there was vacuolation, both intracytoplasmic
(neuronal degeneration) and within the neuropil (spon-
giosis), within the olfactory bulb and spinal cord of some
animals. Varying amounts of single cell death were noted
in all sites where viral antigen was present, and a signifi-
cant number of neurons in the hippocampus were apop-
totic or absent (Fig. 1f , arrow). There was also mild
leptomeningitis with occasional perivascular infiltrates
(minimal encephalitis) in a few mice. At various early
time points, viral antigen was present in the alveolar
septa of the lung and sinus mononuclear cells of the
mandibular lymph node, one of the draining lymph
nodes of the nasal cavity. At later time points, viral anti-
gen was also noted in ganglion cells of the retina (eye),
osteoblasts and fibroblasts lining the trabecular bone
surrounding the nasal cavity, pituitary gland, renal pelvic
tubules (kidney), and myometrium (uterus) (Data not
shown).
Aerosol challenge
Significant immunohistochemical findings and histologic
lesions from the AE study are summarized in Tables 3
and 4, respectively. The findings in the AE study were
similar to IN; however, there were some important dif-
ferences. Analogous to the IN study, viral antigen was
first detected in the olfactory epithelium and lamina pro-
pria of the nasal cavity at 1 dpi (Fig. 2a). However, unlike
the IN study, it was also present in the olfactory nerve
and the olfactory bulb (Fig. 2b) at 1 dpi; the first indica-
tion of neural invasion. By 2 dpi, unlike the IN study, in
the AE study, viral antigen was present in the majority
of mice within the nasal cavity (Fig. 2c), the olfactory
nerve (Fig. 2c, inset), teeth (odontoblasts) and promin-
ently within the olfactory bulb and/or brain, primarily
within the piriform cortex (Fig. 2d) and sporadically
within the thalamus, with. At 3 dpi, viral antigen was
present in the nasal cavity, olfactory bulb, frontal cortex,
and midbrain of all mice, and within the brain stem of 2
animals. Single cell death was easily recognized within
the nasal cavity, olfactory bulb, and cerebrum and was
variably present in other areas where viral antigen was
located. Within the brain, there were variable amounts
Table 1 Significant immunohistochemical findings observed in mice after IN challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi 3 dpi 4 dpi 5 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Head Nasal cavity - - - - - - - - - - +
+
- - - - +
+
++ ++ - - ++ - - ++ - ++ +
+
++ ++ - ++ ++ - ++ ++
Teeth - - - - - - - - - - +
+
- - - - +
+
- ++ - - - - - ++ - ++ +
+
++ - - ++ ++ - ++ ++
Bone - - - - - - - - - - - - - - - - ++ - - - ++ - - ++ - - - - - - - - - - -
Eyes - - - - - - - - - - - - - - - - - - - - - - - - - - +
+
- - - ++ ++ - - -
Brain Olfactory bulb - - - - - - - - - - - - - - - +
+
- ++ - - ++ - - ++ - ++ +
+
++ ++ - ++ ++ - - ++
Frontal cortex - - - - - - - - - - - - - - - +
+
- - - - ++ - - ++ - ++ +
+
++ ++ - ++ ++ - - ++
Midbrain - - - - - - - - - - - - - - - +
+
- - - - ++ - - ++ - ++ +
+
++ ++ - ++ ++ - - ++
Cerebellum - - - - - - - - - - - - - - - - - - - - - - - - - ++ +
+
- ++ - ++ ++ - - ++
Brain stem - - - - - - - - - - - - - - - - - - - - - - - - - ++ +
+
- ++ - ++ ++ - - ++
Pituitary gland - - - - - tnp - - tnp tnp - - - - - - tnp tnp tnp tnp tnp tnp tnp tnp - - - tnp ++ tnp tnp tnp - tnp tnp
Spinal cord - - - - - - - - - - - - - - - - - - - - ++ - - - - ++ +
+
- ++ - ++ ++ - - ++
Salivary
gland
Mandibular - - - - - - - - - - - - - - - - - - - - ++ - - - - - - - - - - - - - -
Haired skin - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Lung - - - - - - - - - - - - - - - - ++ - - - ++ ++ - - - - +
+
- - - - - - - ++
Heart - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Spleen - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Liver - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Lymph
node
Mandibular - - - - - - - - - - - - - - - - ++ - - ++ - - - - - - - ++ ++ - ++ - - - -
Tracheobronchial - - - - - - - - - - - - - - - - - - - - - - - - tnp tnp - - - - - - - - -
Axillary, left - tnp - - - - - - - - - - - - - - - - tnp - - - - - tnp - - - - - tnp tnp tnp - -
Axillary, right - - - - - tnp - - - - - - - - - - tnp - tnp - - tnp tnp tnp - - - - - tnp tnp tnp tnp - tnp
Mesenteric - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Inguinal, left - - - - - - - - - - - - - - - - - - - - - - tnp tnp - tnp - tnp - - tnp tnp - - -
Inguinal, right - tnp tnp tnp tnp tnp - tnp tnp tnp - - - - - - - - - - - - - tnp - - - - - tnp - - tnp - tnp










Table 1 Significant immunohistochemical findings observed in mice after IN challenge with EEEV (Continued)
Popliteal, right - - - - tnp - - - tnp - - - - - - - - - - - - - tnp - - - - - - tnp tnp tnp tnp - -
Thymus - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Thyroid
gland
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - tnp -
Pancreas - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
GI tract - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Kidneys - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ++ - - - -
Urinary
bladder
- - tnp tnp - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Adrenal
glands
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Uterus Myometrium - - - - - - - - - - - - - - - - - - - - ++ - - - - - - - - - - - - - -
Ovaries - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Rear leg,
left
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Rear foot,
left
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Rear leg,
right
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Rear foot,
right
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -










Table 2 Significant histologic lesions noted in mice after IN challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi 3 dpi 4 dpi 5 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Nasal cavity Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - ++ ++ ++ - - ++ - - ++ - ++ ++ ++ - - ++ ++ - ++ ++
Tooth Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - ± - ++ - ± - - - ± - ± ±
Bone Single cell death - - - - - - - - - - - - - - - - - - - - ± - - ± - - - - - - - - - - -
Eyes Ganglion cell loss - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ± - - - -
Olfactory bulb Vacuolation - - - - - - - - - - - - - ± - ± - - - - - - - - - - - - ++ - ++ ++ - - ++
Single cell death - - - - - - - - - - - - - - - - - - - - ± - - ± - ++ ± ± ++ - ++ ++ - - ++
Cerebrum Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - 2mf - - 2mf - - 2mf
Single cell death - - - - - - - - - - - - - - - - - - - - ± - - ± - ++ ± ± ++ - ++ ++ - - ++
Cerebellum Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - - - ++ ± - ± - ++ ++ - - ++
Brain stem Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ++
Spinal Cord Vacuolation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - ++
Single cell death - - - - - - - - - - - - - - - - - - - - - - - - - - ± - - - ++ ++ - - ±
Lung Hemorrhage - - - - - ± - ± ± - - ± ± ± - ± ± - - - ± - - - ± ± ± - - ± ± ± ± ± ±
Inflammation - - - - - - - - - - - - - - - - - - - 2mf - - 2mf 2mf - - - 2mf - - - - - - -
Single cell death - - - - - - - - - - - - - - - - ± - - - ± ± - - - - ± - - - - - - - -
Repro tract Single cell death - - - - - - - - - - - - - - - - - - - - ± - - - - - - - - - - - - - -
Symbols (++, ±, −) indicate whether the lesion was present and easily recognized (++); variably present throughout the tissue (±); or not detected histologically (−). A score of 1–5 indicates the severity of the










Fig. 1 Immunohistochemical and histologic findings in mice after IN infection with EEEV strain FL93-939. Mice were infected with approximately
100LD50 and were euthanized at specified time points (n = 5). Viral antigen was first detected in the nasal cavity at1 dpi (box) (a magnification
X100), specifically the olfactory epithelium and underlying lamina propria (arrow) (b magnification X400). A significant amount of viral antigen
was present in the nasal cavity by 2 dpi, but was restricted to the olfactory epithelium (arrows); the respiratory epithelium was not involved (arrow
head) (c magnification X40). Viral antigen was first detected in the olfactory bulb at 2 dpi (d magnification X400). Viral antigen was present
throughout the brain by 5 dpi (e magnification X20) and there was significant neuronal cell death (hypereosinophilic, shrunken neurons with
pyknosis or karyorrhexis, arrow) in the hippocampus (f magnification X200)
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ingoencephalitis in some mice. This arm of the study
was terminated on 4 dpi because a majority of remaining
mice had severe clinical disease. Therefore, the 4 dpi
group consisted of 10 mice. In 9 of these mice, viral anti-
gen was multifocally to diffusely present throughout
nasal cavity, olfactory bulbs, frontal cortex, midbrain
(Fig. 2e), cerebellum, and brain stem, as well as the
spinal cord, lung and pituitary gland. Again, single cell
death without inflammation (apoptosis) was easily recog-
nized in all tissues, including the cerebrum (Fig. 2f,
arrow), in which viral antigen was present. Similar to the
lesions noted at 3 dpi, there was variable neuronal vacu-
olation, spongiosis, and moderate meningoencephalitis
(Fig. 2f ) in the brain of some mice. In situ hybridization
results correlated with the distribution of viral antigen
(data not shown). Similar to the findings in the IN study,
viral antigen was variably present after 1 dpi in the lung
(alveolar septa, adjacent to terminal bronchioles), eye(ganglion cells of the retina), reproductive tract (myome-
trium and/or ovary), and renal pelvic epithelium (Data
not shown).
Subcutaneous challenge
Significant immunohistochemical findings and histologic
lesions from the SC study are summarized in Tables 5
and 6, respectively. The results of the SC (left footpad)
study were quite different than the IN and AE studies.
As expected, viral antigen was present at the inoculation
site (left footpad) from 6 hpi, and remained within the
left foot to varying degrees throughout the study. Viral
antigen was noted in the left popliteal lymph node, the
draining lymph node of the foot and lower leg, from 6
hpi (Fig. 3a) through 2 dpi. Cells most commonly posi-
tive for viral antigen in the foot included synovial cells
(Fig. 3b), connective tissue fibroblasts (Fig. 3c), and skel-
etal myocytes; however, antigen was also present in and
around hair follicles, within the epidermis and
Table 3 Significant immunohistochemical findings observed in mice after AE challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Head Nasal cavity - - - - - - - - - - - ++ ++ - ++ ++ ++ - ++ ++
Teeth - - - - - - - - - - - - - - - ++ ++ - - ++
Bone - - - - - - - - - - - - - - - - - - - -
Eyes - - - - - - - - - - - - - - - - - - - -
Brain Olfactory bulb - - - - - - - - - - - - - - ++ ++ ++ - ++ -
Frontal cortex - - - - - - - - - - - - - - - ++ ++ - ++ -
Midbrain - - - - - - - - - - - - - - - ++ - - - -
Cerebellum - - - - - - - - - - - - - - - - - - - -
Brain stem - - - - - - - - - - - - - - - - - - - -
Pituitary gland - tnp - - tnp - tnp - - tnp - - - - - ++ - - - -
Spinal cord - - - - - - - - - - - - - - - - - - - -
Salivary gland Mandibular - - - - - - - - - - - - - - - - - - - -
Haired skin - - - - - - - - - - - - - - - - - - - -
Lung - - - - - - - - - - - - - - - ++ ++ - - -
Heart - - - - - - - - - - - - - - - - - - - -
Spleen - - - - - - - - - - - - - - - - - - - -
Liver - - - - - - - - - - - - - - - - - - - -
Lymph node Mandibular - - - - - - - - - - - - - - - tnp - - - -
Tracheobronchial - - - - - - - - - - - - - - - - - - - -
Axillary, left - - tnp - tnp - - - - tnp - - tnp - - - - - - -
Axillary, right - - - - - - - - - - - - - - - tnp - - - -
Mesenteric - - - - - - - - - - - - - - - - - - - -
Inguinal, left - - - - - - - - - - - - tnp - - - - tnp tnp tnp
Inguinal, right - tnp tnp - - - - - - - - - - - - - - - tnp -
Popliteal, left - - - tnp - tnp tnp - tnp - tnp - tnp - - - tnp tnp - tnp
Popliteal, right tnp - tnp - - tnp tnp - tnp tnp tnp tnp - - - - - - - tnp
Thymus - - - - - - - - - - - - - - - - - - - -
Thyroid gland tnp - - - - - tnp - tnp tnp tnp - - - - - - tnp tnp -
Pancreas - - - - - - - - - - - - - - - - - - - -
GI tract - - - - - - - - - - - - - - - - - - - -
Kidneys - - - - - - - - - - - - - - - - - - - -
Urinary bladder - - - - - - - - - - - - - - - - - - - -
Adrenal glands - - - - - - - - - - - - - - - - - - - -
Uterus Myometrium - - - - - - - - - - - - - - - ++ - - - ++
Ovaries - - - - - - - - - - - - - - - ++ ++ - - ++
Rear leg, left - - - - - - - - - - - - - - - - - - - -
Rear foot, left - - - - - - - - - - - - - - - - - - - -
Rear leg, right - - - - - - - - - - - - - - - - - - - -
Rear foot, right - - - - - - - - - - - - - - - - - - - -
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Table 3 Significant immunohistochemical findings observed in mice after AE challenge with EEEV (Continued)
3 dpi 4 dpi 5 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ ++ ++ ++ ++
++ ++ - - ++ ++ ++ ++ - - ++ ++ ++ ++ ++
- - - - - - - - - - - - - - -
- - - - - ++ ++ ++ - - - - - ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ - ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ ++ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ ++ ++ ++ ++
- - - - - ++ ++ ++ - - ++ ++ ++ ++ ++
++ - ++ - tnp ++ ++ ++ ++ - ++ ++ ++ ++ ++
- - - - ++ ++ ++ ++ - - - tnp tnp ++ ++
- - - - ++ ++ ++ ++ - - ++ ++ ++ ++ ++
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
++ ++ - ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
- - - - - - - - - - - ++ - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - tnp - - - - -
- - - - - - - - - - - - - - -
- - - - - - tnp - tnp tnp - - - - -
- - - - - tnp tnp tnp - tnp - - - - -
- tnp tnp - - - - - - - - - - tnp tnp
tnp - tnp - tnp tnp - - tnp - - - - - -
- - - - - - - - - - - - - - -
tnp tnp - tnp tnp - tnp tnp tnp tnp - tnp tnp - -
tnp - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - ++
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - ++ - - ++ ++ ++ - ++ - - -
- - ++ - - - - - - - - ++ - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
- - - - - - - - - - - - - - -
Symbols (++, ±, −) indicate that viral antigen was present and easily recognized (++); variably present throughout the tissue (±); or not detected histologically (−).
Tnp = tissue not present on slide
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Table 4 Significant histologic lesions noted in mice after AE challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi 3 dpi 4 dpi 5 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Nasal cavity Inflammation - - - - - - - - - - - - - - - - - - 3mf - 3fe - - 3fe - - - - - - 3mf - - 3fe 3mf
Single cell death - - - - - - - - - - - ++ ± - ± ++ ++ - ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ ++ ++ ++ ++
Tooth Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - ± ± ± - ± ± ± ± ± - - ± ± ± - ±
Bone Single cell death - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Eyes Ganglion cell loss - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Olfactory bulb Vacuolation - - - - - - - - - - - - - - - - ± - - - - ± ± - ± ± - ± - - ± - ± ± ±
Single cell death - - - - - - - - - - - - - - - ± ± - - - ++ ++ ++ ++ ++ ++ ++ ++ ++ - ++ - ++ ++ ++
Cerebrum Inflammation - - - - - - - - - - - - - - - - - - - - - - - - ++ ± ± ± - - ++ - ++ ± ±
Single cell death - - - - - - - - - - - - - - - - - - - - - - ++ - - - - - - - - - - - -
Cerebellum Inflammation - - - - - - - - - - - - - - - - - - - - 3d - 2mf - 4mf - - 3d 3d - 3d - 3d - 3mf
Single cell death - - - - - - - - - - - - - - - ± - - - - ++ ± ++ ± ++ ++ ++ ++ ++ - ++ - ++ ++ ++
Brain stem Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - ± - ± - - ± ± ± ± - ± ± ± ± ±
Spinal Cord Vacuolation - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3mf -
Single cell death - - - - - - - - - - - - - - - - - - - - ± - ± - - - - - - - ± ± ± ± ±
Lung Hemorrhage - - - - - - - - - - - - - - - - - - - - - - - - - ± - - - - - - - - -
Inflammation - - - - - - - - - - - - - - - - - - - - - - - - - ± ± ± - - ± - ± ± ±
Single cell death - - - - - - - - - - ± - ± - - - - - - - - - - - - - ± ± - - - - ± - -
Repro tract Single cell death - - - - - - - - - - - - - - - 2fe - - - - 2fe - - 2mf - - - - - - - - - - -
Symbols (++, ±, −) indicate whether the lesion was present and easily recognized (++); variably present throughout the tissue (±); or not detected histologically (−). A score of 1–5 indicates the severity of the










Fig. 2 Immunohistochemical and histologic findings in mice after AE infection with EEEV strain FL93-939. Mice were infected with approximately
100LD50 and were euthanized at specified time points (n = 5, except 4dpi n = 10). Viral antigen was first detected in the olfactory nasal epithelium,
lamina propria, and olfactory nerve (a magnification X200), as well as the olfactory bulb at 1 dpi (b magnification X200). Multifocally, viral antigen
was present in the nasal cavity (c magnification X20), the olfactory nerve (c; inset, magnification X400), and cerebrum, especially the piriform cortex, by
2 dpi (d magnification X20). Viral antigen was present throughout the brain by 3 dpi (e magnification X20) and there was meningoencephalitis in the
cerebrum (f magnification X200) and multifocal neuronal cell death (hypereosinophilic, shrunken neurons with pyknosis or karyorrhexis; inset, arrow)
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site. No significant histologic lesions were noted in the
left foot until 1 dpi when scattered single cell death was
apparent. Single cell death (apoptosis), cellulitis, and
myocyte degeneration, necrosis and regeneration were
noted in most mice, to varying degrees, in the left foot
from 2 dpi through the end of the study (Data not
shown). Similar to the results of the IN study, in the
lymph node, viral antigen was only found in histocytes
and/or cells with morphologic features of dendritic cells
within the subcapsular sinus, not within the follicles of
the cortex. Unlike the IN and AE studies where viral
antigen was first noted in the nasal cavity olfactory epi-
thelium and lamina propria at 1 dpi, in the SC study this
occurred 2 days later, at 3 dpi (Fig. 3d) and was detected
in a low number of mice through 7 dpi. From 4 dpi
through 8 dpi, viral antigen was detected in either the
olfactory epithelium/lamina propria and/or the teeth in
only 8 of 25 mice; viral antigen was also detected in the
olfactory bulb or cerebrum in 7 of those 8 animals, 4 ofwhich had viral antigen throughout the cerebrum, cere-
bellum (Fig. 3e), and brain stem. Significantly, these 4
mice also had moderate-marked neuronal apoptosis,
spongiosis, meningoencephalitis, as well as vasculitis,
thrombosis, and perivascular hemorrhage (Fig. 3f, ar-
rows), which was not seen in either the IN or AE stud-
ies. Interestingly, viral antigen was not closely associated
with the areas of vasculitis or thrombosis (Fig. 3f, inset,
between arrows). In one mouse at 7 dpi, viral antigen
was detected throughout the brain, but was not detected
in either the nasal cavity or teeth. However, histologically
there was a significant mucosal hyperplastic response
along with a marked secondary bacterial rhinitis.
In an attempt to further elucidate the mechanism of
neuronal cell death, brain sections from the AE study
were evaluated immunohistochemically for the presence
of cleaved-caspase-3 antigen as a marker of apoptosis as
well as LC3BII antigen as a marker of autophagy. While
there were very few cells in the control animals that had
intracytoplasmic staining for cleaved-caspase-3 antigen
Table 5 Significant immunohistochemical findings observed in mice after SC challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi 3 dpi
6 7 8 9 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Head Nasal cavity - - - - - - - - - - - - - - - - - - - - - - - ++
Teeth - - - - - - - - - - - - - - - - - - - - - - - ++
Bone - - - - - - - - - - - - - - - - - - - - - - - -
Eyes - - - - - - - - - - - - - - - - - - - - - - - -
Brain Olfactory bulb - - - - - - - - - - - - - - - - - - - - - - - -
Frontal cortex - - - - - - - - - - - - - - - - - - - - - - - -
Midbrain - - - - - - - - - - - - - - - - - - - - - - - -
Cerebellum - - - - - - - - - - - - - - - - - - - - - - - -
Brain stem - - - - - - - - - - - - - - - - - - - - - - - -
Pituitary gland - - tnp - - - tnp - - - tnp - tnp - - - - tnp - - - - - -
Spinal cord - - - - - - - - - - - - - - - - - - - - - - - -
Salivary gland Mandibular - - - - - - tnp - - - - - - - - - - - - - - - - -
Haired skin - - - - - - - - - - - - - - - - - - - - - - - -
Lung - - - - - - - - - - - - - - - - - - - - - - - -
Heart - - - - - - - - - - - - - - - - - - - - - - - -
Spleen - - - - - - - - - - - - - - - - - - - - - - - -
Liver - - - - - - - - - - - - - - - - - - - - - - - -
Lymph node Mandibular - - - - - - - - - - - - - - - - - - - - - ++ - -
Tracheobronchial - - - - - - - - - - - - - - - - - - - - tnp - tnp -
Axillary, left - - tnp - - - - tnp - - - tnp - - - - - - - tnp - tnp - -
Axillary, right - - - - - - - - tnp - - - tnp - tnp - - - - - - - tnp -
Mesenteric - - - - - - - - - - - - - - - - - - - - - - - -
Inguinal, left - - - - - - - - - - - - - - tnp - tnp - - - - - - -
Inguinal, right tnp - tnp tnp tnp tnp - tnp - - - tnp tnp tnp tnp - - - - - - - - tnp
Popliteal, left ++ - - tnp ++ tnp ++ ++ ++ ++ tnp tnp ++ ++ tnp ++ - - - - tnp - - -
Popliteal, right - - - tnp tnp - - tnp - - +++ tnp tnp tnp tnp - - - - - - - - -
Thymus - - - - - - - - - - - - - tnp - - - - - - - - - -
Thyroid gland tnp tnp - - - - - - tnp - tnp - - tnp tnp tnp - tnp - - - - - -
Pancreas - - - - - - - - - - - - - - - - - - - - - - - -
GI tract - - - - - - - - - - - - - - - - - - - - - - - -
Kidneys - - - - - - - - - - - - - - - - - - - - - - - -










Table 5 Significant immunoh ochemical findings observed in mice after SC challenge with EEEV (Continued)
Adrenal glands - - - - - - - - - - - - - - - - - - - - - - - -
Uterus Myometrium - - - - - - - - - - - - - - - - - - - - - - - -
Ovaries - - - - - - - - - - - - - - - - - - - - - - - tnp
Rear leg, left - - - - - - - - - - - - - - - - - - - - - - - -
Rear foot, left ++ - - - ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Rear leg, right - - - - - - - - - - - - - - - - - - - - - - - -










Table 5 Significant immunohistochemical findings observed in mice after SC challenge with EEEV (Continued)
4 dpi 5 dpi 6 dpi 7 dpi 8 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
- - ++ - - - - - - ++ - - - ++ ++ - - - - ++ - - - - -
- ++ ++ ++ - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - ++ - ++ - - - - - - - - -
- ++ ++ - - - - - - ++ - - - ++ ++ ++ - - - ++ - - - - -
- - ++ ++ - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - ++ - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - ++ - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - ++ - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
tnp tnp tnp tnp - - - tnp tnp - - tnp - - - - - tnp - ++ - - ++ tnp -
- - - - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - ++ - - - - - - - - - - - - - - tnp
- - - - - - - - - - - - - - - - - - - - - - tnp - -
- - - - - - - - - - - tnp - - - - - - - tnp - - - - -
- - - - - - - - tnp - - - - - - - - - t - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - tnp
- - - - - - - - - - - - - - - - - - - - - - - - tnp
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - tnp tnp - - - - - - - - - - - tnp - tnp tnp - - - -
- tnp - - - - - - - - - - - - - - - - - - - - - - -
tnp tnp - - tnp - - - - - tnp - - - tnp - tnp tnp - tnp - tnp tnp - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -










Table 5 Significant immunohistochemical findings observed in mice after SC challenge with EEEV (Continued)
- - - - - - - - - - - - - - - - - - - - - - tnp - -
- - - - - - - - - - - - - - - - - - - - - - - - tnp
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - tnp - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ + ++ ++ - - ++ -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -











Table 6 Significant histologic lesions noted in mice after SC challenge with EEEV
Tissue 6 hpi 12 hpi 1 dpi 2 dpi 3 dpi
6 7 8 9 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
Nasal cavity Inflammation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - ±
Tooth Inflammation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - ±
Bone Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Eyes Ganglion cell loss - - - - - - - - - - - - - - - - - - - - - - - -
Olfactory bulb Vacuolation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Cerebrum Inflammation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Cerebellum Inflammation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Brain stem Inflammation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Spinal Cord Vacuolation - - - - - - - - - - - - - - - - - - - - - - - -
Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
Lung Hemorrhage - - - - - - - - - - - - - - - - - - - - - - - -
Inflammation - - - - - - - - - - - - - - 3mf 2mf 2mf 3mf 2mf 3mf 2mf 4mf 3mf 4mf
Single cell death - - - - - - - - - ± ± ± ± ± ++ ++ ± ++ ± ± ± ++ ++ ++
Repro tract Single cell death - - - - - - - - - - - - - - - - - - - - - - - -
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Table 6 Significant histologic lesions noted in mice after SC challenge with EEEV (Continued)
4 dpi 5 dpi 6 dpi 7 dpi 8 dpi
6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10 6 7 8 9 10
- - - - - - - - - - - - - 5mf 5mf 5mf - - - 3mf - - - - -
- - ++ - - - - - - ++ - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - ++ - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - ++ - - - ++ - - - - -
- ± ± - - - - - - ± - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - 4d 4d 4d - - - 4d - - - - -
- - ± ± - - - - - - - - - ++ ++ ++ - - - ++ - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - ± - - - - - - - - - - ± ± ± - - - ± - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - -
- - ± - - - - - - - - - - ± ± ± - - - ± - - - - -
- - - - - - - - - - - - - 3mf 2mf 2mf - - - 2mf - - - - -
- - - - - - - - - - - - - ± ± ++ - - - ++ - - - - -
- 3mf 2mf 2mf 2fe 2mf 2fe - 2mf 2mf 2mf - 3mf - - 2mf 3mf 3mf 4mf 2fe 2fe - 3mf 3mf 3fe
± ± ++ ++ ± ± ± - ± ± - - - ± - - ± - - - - - ± ± ±
- - - - - - - - - - - - - - - - - ± ± ± ± - ± ± ±
Symbols (++, ±, −) indicate whether the lesion was present and easily recognized (++); variably present throughout the tissue (±); or not detected histologically
(−). A score of 1–5 indicates the severity of the inflammation: 1 (minimal); 2 (mild); 3 (moderate); 4 (marked); 5 (severe). Distribution of the lesion: f (focal); fe
(focally extensive); mf (multifocal); d (diffuse)
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cells staining for the apoptotic marker in the olfactory
bulb of EEEV infected mice, especially after 2 dpi
(Fig. 4b), this trend continued through 4 dpi (Fig. 4c).
The cleaved-caspase 3 antigen was also detected within
the cerebrum, especially within the piriform cortex
(Fig. 4d) and within cells with karyorrhexis (Fig. 4d,
inset, arrow) as well as within some inflammatory cells
within the meninges. The antigen remained present
within the cerebrum, especially the piriform cortex, at
low levels through 4 dpi, the study endpoint.
LC3BII is typically noted as cytoplasmic punctate
staining in cells undergoing autophagy. While autophagy
can be part of normal cellular turnover in the brain,
staining was not evident in uninfected control animals.
Overall, there were only a few neurons containing intra-
cytoplasmic punctate staining; however, these were in
areas that were positive for viral antigen. LC3BII antigen
was noted in 3/5 mice in the olfactory bulb, in both the
external plexiform and internal granular layers, at 3 dpi.
At 4 dpi, 6 out of 10 animals had low numbers of neu-
rons in the olfactory bulb, frontal cortex (Fig. 4e), and
midbrain which contained intracytoplasmic punctate
staining (Fig. 4f, arrow) for LC3BII. This suggests thatwhile autophagy occurs in EEEV infected mice, it does
not occur until later in the disease and that only a small
number of neurons are removed by this process.
Discussion
In order to better understand the pathogenesis of EEEV
strain FL93-939 several studies were conducted to evalu-
ate the differences between three routes of infection:
subcutaneous, aerosol, and intranasal. Subcutaneous in-
oculation is intended to mimic a mosquito-acquired in-
fection. Aerosol exposure is a likely route in the event of
an intentional release of EEEV and accidental laboratory
exposure. Finally, intranasal exposure is often used by
labs as a substitute for aerosol infection by labs not pos-
sessing the specialize equipment necessary to carry out
an aerosol exposure, necessitating a comparison of the
two routes. Although the intranasal and aerosol routes
had similar findings, there were important pathological
differences noted, most prominently that viral antigen
was detected in the brain at 1 dpi in the AE study as
compared to 2 dpi in the IN study; that viral antigen was
present in the brain of most animals in the AE study by
2 dpi and throughout the brain by 3 dpi. This increas-
ingly rapid spread in the AE study correlated with
Fig. 3 Immunohistochemical and histologic findings in mice after SC (left footpad) infection with EEEV strain FL93-939. Mice were infected with
approximately 30LD50 and were euthanized at specified time points (n = 5). Viral antigen was first detected in the left popliteal (draining) lymph
node at 6 hpi (a magnification X400). At the inoculation site, viral antigen was present in synovial cells at 12 hpi (b magnification X200).
Viral antigen was found in numerous fibroblasts in the left foot at 2 dpi (c magnification X200). Viral antigen was first detected in the
olfactory epithelium at 3 dpi (d magnification X200) and was present throughout the brain, including the cerebellum by 4 dpi (e magnification X20).
Within the cerebrum there was meningoencephalitis with vasculitis, thrombosis, hemorrhage (arrows), and spongiosis by 6 dpi (f magnification X400);
however, viral antigen was not present around thrombotic vessels (inset, between arrows)
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earlier than those in the IN study.
In additional studies, we used virus titration of tissue
homogenates to complement the histopathology and im-
munohistochemistry presented here and further define
the pathogenesis of EEEV strain FL93-939 in mice [10].
Not surprisingly, viral titration was much more sensitive
than IHC in detecting the presence of virus at early time
points. In the IN study, virus was first detected in the
blood and the brain homogenate at 1 dpi; however, at
this time, viral antigen was only noted in the nasal cavity
(olfactory epithelium and lamina propria) and not the ol-
factory bulb or cerebrum immunohistochemically. The
bipolar olfactory neuron, found in the olfactory epithe-
lium is instrumental as one pole of the cell has cilia that
project into the air passages, a likely site of viral contact,
and the opposite pole extends an axon that synapses dir-
ectly with neurons of the olfactory bulb. Therefore, vi-
ruses that target olfactory neurons have a direct conduitto the brain. This appeared to be the case in this study,
because by 2 dpi, when viremia peaked and titer in the
brain rapidly increased, there was viral antigen present
multifocally within the nasal cavity and also within the
olfactory bulb. In the one animal in which viral antigen
was detected in the frontal cortex and midbrain, it was
present in only a few scattered cells primarily within the
piriform cortex. Virus then appeared to spread in a ros-
tral to caudal fashion, infecting neurons of the cerebel-
lum and brain stem only at the later time points.
Overall, these findings suggest the virus entered the
brain via the olfactory route rather than the vascular
route, which is similar to that seen in guinea pigs ex-
posed to aerosolized EEEV [11].
The results for the AE study were very similar to the
results of the IN study, with the important exception
that virus was detected in the brain by titer at only 6 hpi
and viral antigen was present in the olfactory bulb by 1
dpi, a day earlier than in the IN study. The virus
Fig. 4 Immunohistochemical findings for cleaved-caspase 3 (a-d) and LC3BII (e-f) in mice after AE infection with EEEV strain FL93-939. Mice were
infected with approximately 100LD50 and were euthanized at specified time points (n = 5). While cleaved-caspase 3 antigen was detected in very
few cells in the olfactory bulb (a magnification X400), there was increased antigen detected in the olfactory bulb by 2 dpi (b magnification X100).
The increase in cleaved-caspase 3 antigen detection in the olfactory bulb continued through the study and was present in clusters of cells at 4
dpi (c magnification X100). Cleaved-caspase 3 antigen was present within the cerebrum, primarily within the piriform cortex (d magnification
X100) and specifically within cells with karyorrhexis (d inset, arrow) as well as within some inflammatory cells within the meninges. The LC3BII
antigen was detected in low numbers of neurons within the olfactory bulb, frontal cortex (e magnification X100), and midbrain at 3–4 dpi. The
antigen was cytoplasmic and punctate in affected cells (f magnification X400, arrow)
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and spread transneuronally, rostral to caudal, as noted in
the IN study; however this occurred more rapidly and
more frequently at each time point. The aerosol delivery
method likely allowed more viral contact with olfactory
neurons, thus facilitating the earlier viral invasion of the
olfactory bulb and subsequent transport to the olfactory
tract and beyond. These results support the clinical find-
ings of more rapid and severe disease onset in this study
compared to the IN or SC studies.
The results of the SC study were less clear, which may
be due to the dose and/or route of inoculation.
Throughout the study, evidence of viral infection was
not observed consistently. While virus was first detected
in the brain by standard plaque assay at 1 dpi (1 of 5 an-
imals, 20 %), virus was only detected in 10 of 60 (17 %)
of animals from 3–8 dpi. Similar inconsistencies were
observed on pathological examination of the tissues.Viral antigen was only detected in the nasal cavity and/
or brain in 10 of 60 animals from 3–8 dpi. In some ani-
mals, viral antigen was detected in the nasal cavity and
olfactory bulb, while in others it was detected in the
nasal cavity and throughout the brain simultaneously.
This could be a result of individual animal variability or
the result of vascular spread to the brain. These results
are similar to those found by Vogel et al. [12]; however,
in that study it was noted that the virus generally spared
the olfactory epithelium. Similar to their study, viral rep-
lication was observed at the inoculation site, in fibro-
blasts, skeletal myocytes, and synovial cells; however,
unlike in the Vogel study, no viral antigen was detected
in osteoblasts of the long bones in this study. This is
likely due to the age difference of the mice used in
each of the studies. In the Vogel study, the mice were
5-weeks old and the mice were actively growing with
open growth plates and high numbers of osteoblasts,
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which is considered an adult characterized by closed
growth plates and relatively few osteoblasts. Also, in con-
trast to the Vogel study, a few animals in this SC study
had moderate to marked meningoencephalitis with vascu-
litis, thrombosis, and hemorrhage at 6–7 dpi. Interest-
ingly, viral antigen was not present adjacent to affected
vessels, suggesting this lesion could be immune-mediated
rather than a direct result of viral infection. Meningo-
encephalitis and vasculitis have been associated with
EEEV after natural infection in humans and aerosol expos-
ure in guinea pigs [11], but have not been previously re-
ported in mice. Our findings may be due to the lower
inoculation dose and/or the prolonged study design,
which may actually mimic natural human infection more
accurately.
In humans, the incubation period following natural in-
fection is short, usually 4–10 days; however, in most
cases the exact time of exposure is not known. Systemic
infection is often characterized by abrupt onset of chills
and fever followed by malaise, arthralgia, and myalgia.
Typically, these are difficult parameters to measure in
animals; however, telemetry did allow monitoring of
temperature and activity and fever and decreased activity
(lethargy or malaise) were observed in many infected an-
imals. Clinical signs of encephalitis in humans include
abrupt onset of fever, intense headache, irritability, rest-
lessness, drowsiness, anorexia, nausea, vomiting, diar-
rhea, cyanosis, convulsions, and coma. Again, while
most of these clinical signs cannot be evaluated in mice,
marked lethargy and tremors were noted in some in-
fected animals. In humans, death usually occurs within
2–14 days after the onset of clinical signs [1]. Similarly,
mice in these studies generally were moribund or suc-
cumbed to infection within 2–4 days following the onset
of clinical signs. The slightly longer time course in
humans may be due to species differences or the more
intensive supportive care typically provided to humans
with neuroinvasive disease. Histopathologic lesions in
human cases of EEE include vasculitis, thrombosis, peri-
vascular cuffing, neutrophilic and histiocytic infiltrates,
neuronal cell death, neuronophagia, focal necrosis, de-
myelination, and gliosis [13]. While vasculitis, throm-
bosis, and inflammation were not prominent lesions in
the IN or AE studies, these histopathologic changes were
noted in several animals, especially after 5 dpi, in our SC
study. Neuronal cell death, regardless of mechanism of
cell death, is a universal key feature in this disease and
has been noted in all animal models studied [6, 11,
12, 14]. Again, the lower dose, slightly longer clinical
course, and the histopathological lesions noted in the
SC study likely more closely mimic the natural dis-
ease seen in humans, making this mouse model a
useful tool for further investigation and evaluation ofmedical countermeasures. Additionally, the results pre-
sented here support the finding by Roy et. al. in which
aerosolized EEEV in guinea pigs entered the brain through
the olfactory system followed by transneuronal spread to
all regions of the brain with viral antigen detected immu-
nohistochemically in the olfactory mucosa, the olfactory
nerves, and/or lamina propria 1 dpi [11]. To date, no pub-
lished NHP studies have evaluated the mechanism of neu-
roinvasion of EEEV following aerosol exposure [6, 14–16].
While it is likely that EEEV utilizes the olfactory system to
invade the brain in NHP, this is an important question
that remains to be answered.
To further elucidate the mechanism of neuronal cell
death in the mouse model, brain sections from the AE
study were evaluated for the presence of cleaved-caspase
3 antigen as a marker of apoptosis as well as LC3B-II
antigen as a marker of autophagy. While there was a low
basal level of apoptosis present in control animals, sig-
nificantly more was present in EEEV infected animals,
especially at later time points. Cleaved-caspase 3 antigen
was found primarily in the neurons of the olfactory bulb
and the piriform cortex of the cerebrum. However, the
number of cells staining for cleaved-caspase-3 was lower
than expected based on histologic findings. At later time
points, a significant number of neurons with condensed
cytoplasm and either pyknosis or karyorrhexis, suggest-
ive of apoptosis, were present. This disparity may be due
to the fact that cleaved-caspase 3, a marker in the ter-
minal pathway of apoptosis, may not be present in cells
that have already undergone apoptosis with resultant
cellular and nuclear fragmentation. On the other hand,
it may be that some neurons are not undergoing apop-
tosis but are dying by another mechanism, such as ne-
crosis or autophagy. Autophagy, also known as type II
programmed cell death, has been recognized as a means
of cellular death in other alphaviral infections [17, 18]
and can be histologically indistinguishable from apop-
tosis. We found relatively few neurons that were immu-
nohistochemically positive for LC3B-II antigen, and
these were only present at 3–4 dpi. The positive neurons
were within viral antigen positive areas within the olfac-
tory bulb, frontal cortex, and midbrain, but specifically
not within the piriform cortex. This suggests that neu-
rons in various areas of the brain may respond to viral
infection differently and ultimately undergo one of sev-
eral mechanisms of cell death.
It is important to note that histologically it can be dif-
ficult to determine the mechanism of cell death for each
individual neuron as apoptosis, necrosis, and autophagy
can occur simultaneously in the same tissue. The mor-
phological features of apoptosis are generally character-
ized by cell shrinkage and convolution, pyknosis and
karyorrhexis, intact cell membranes with no inflamma-
tion affecting single cells or small clusters of cells, while
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characterized by cell swelling, karyolysis, and disruption
of cell membranes with inflammation affecting contigu-
ous cells. However, pyknosis and karyorrhexis can be
seen in necrosis as well as apoptosis [19] and recent
studies indicate that necrosis may not only be an acci-
dental form of cell death, but that it may be initiated or
modulated by programmed control mechanisms, much
like apoptosis and autophagy [20–23]. There is overlap
between these two processes, which has been described
as the “necrosis-apoptosis continuum” and whether a
cell dies by necrosis or apoptosis may be determined by
the tissue type, developmental stage of the tissue, cell
death signal, as well as the physiologic microenviron-
ment [24, 25]. Autophagy is a more recently recognized
form of programmed cell death. While autophagy is gen-
erally recognized as an adaptive response, there is some
controversy as to its role in cell death. It is uncertain if
the accumulation of autophagosomes in some dying cells
is a consequence of cellular adaptation alone or if these
structures actually facilitate cell death [22]. As the
molecular pathways of these processes become more de-
fined, it may be revealed that the various mechanisms of
cell death work in concert to eliminate unwanted cells in
order to preserve tissue and organ function.
It is widely accepted that the brain is composed of nu-
merous morphologically, metabolically, and functionally
diverse neuroanatomic regions, which have differential
sensitivities to various toxic and infectious insults. While
neurons can be broadly classified as “small neurons” and
“large neurons”, various subtypes of each exist and inter-
act with a number of support cells of varying function
[26]. With the complexity and mutually supportive roles
of the numerous cell types within the CNS just begin-
ning to be understood, it is not difficult to imagine that
one or more mechanisms of cell death may play an im-
portant role in overall maintenance of brain function. As
our study suggests, in mice infected with EEEV, neurons
in the CNS may undergo cell death by apoptosis, necro-
sis, or autophagy depending on the neuroanatomic loca-
tion of the neuron and stage of disease. Ultimately, if
one or more mechanisms of cell death are consistently
identified in animal models of EEEV, these could repre-
sent additional targets for therapeutic intervention. If
neuronal death could be prevented or if fewer neurons
are lost during neuroinvasive disease, this could signifi-
cantly improve the long term neurological sequelae that
are often noted in human cases.
Conclusion
While it has long been known that in mice infected with
VEEV, regardless of route of exposure, neuroinvasion oc-
curs through the olfactory system [6, 27–30], this study
has been crucial in understanding the mechanism ofneuroinvasion of EEEV. It is clear from these studies
that EEEV enters the brain through the olfactory system
when mice are exposed either by the intranasal or aero-
sol route, with the aerosol route resulting in neuroinva-
sion approximately 1 day earlier than the nasal route.
The mechanism and rapidity of virus entry into the
brain has important vaccine and therapeutic implica-
tions. First, for a vaccine to be effective, it must prevent
the virus from infecting olfactory neurons. Since the
nasal cavity is a mucosal surface, it would be reasonable
to expect that an effective vaccine would induce the pro-
duction of neutralizing IgA as well as IgG. Secondly,
since viral antigen was present within the brain at 1 dpi
in the aerosol study, a useful therapeutic would need to
be administered very soon after exposure and would
have to be formulated to easily cross the blood–brain-
barrier. Lastly, while the subcutaneous route most
closely mimics human disease, when developing medical
countermeasures, it is important to test them against
multiple routes of infection, including aerosol or intra-
nasal. These are not insurmountable tasks; however,
these factors must be taken into account in the develop-
ment of vaccines, post-exposure prophylaxis and thera-
peutics for EEEV infection.Methods
Mice
Specific pathogen free, 8–10 week-old female BALB/c
mice (NCI, Frederick, MD) were housed in cages
equipped with microisolators and were provided food
and water ad libitum throughout the study. The room
temperature was 23 ± 1 °C and periods of light and dark
were maintained on a 12 h cycle. Mice were acclimated
for 1 week then housed in a biosafety level 3 (BSL-3)
facility. Research was conducted under an IACUC ap-
proved protocol in compliance with the Animal Welfare
Act, Public Health Service Policy, and other Federal stat-
utes and regulations relating to animals and experiments
involving animals. The facility where the research was
conducted is accredited by the Association for the
Assessment and Accreditation of Laboratory Animal
Care International and adheres to principles stated in
the Guide for the Care and Use of Laboratory Animals,
National Research Council, 2011.Virus
EEEV strain FL93-939 was obtained from Dr. Scott
Weaver, UTMB, Galveston, TX. A sucrose-purified work-
ing stock was prepared from seed stock (P1) through an
additional passage (P2) in Vero cells. Virus titer was deter-
mined by standard plaque assay on Vero cell monolayers.
Challenge virus was diluted in either Eagle’s minimum es-
sential medium (EMEM) (Cellgro, Mediatech, Manassas,
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Invitrogen Corp., Grand Island, NY).
Experimental design
Groups of 10 mice were exposed to approximately
30-100LD50 of EEEV strain FL93-939 by either the in-
tranasal, aerosol or subcutaneous route. For the intra-
nasal route of exposure, virus dose was prepared in a
20 μL volume in sterilized PBS. Control mice received
only sterilized PBS. Mice were briefly anesthetized
with isoflurane using the IMPAC6 (VetEquip, Inc.,
Pleasanton, CA) and given 10 μL of challenge virus
per nostril. For the aerosol route of exposure, virus
dose was prepared in a 10 ml volume in EMEM.
Control mice were exposed to diluent only. Aerosol
exposures were conducted in a whole-body bioaerosol
exposure system. A Collison nebulizer (BGI, Inc.,
Waltham, MA) was used to generate small (1 μm
mass median aerodynamic diameter) diameter parti-
cles for each acute 10 min exposure. Briefly, mice
were placed in wire cages, which were then placed
into a chamber where they were exposed to
aerosolized virus for 10 min. ‘Presented’ dose was es-
timated by calculating the respiratory minute volume
(Vm) using Guyton’s formula [31], expressed as Vm =
2.10 x Wb
0.75 where Wb = body weight (gm) based on
the average group weights the day of exposure. The
presented dose was then calculated by multiplying the
estimated total volume (Vt) of experimental atmos-
phere inhaled by each animal (Vt = Vm x length of
exposure) by the empirically determined exposure
concentration (Ce) (‘presented dose’ = Ce x Vt). Expos-
ure concentration, expressed in plaque-forming units
(PFU)/L, was determined by isokinetic sampling of
the chamber with an all-glass impinger (AGI) (Ace
Glass, Vineland, NJ). Samples were titrated by stand-
ard plaque assay on Vero cell monolayers [32]. For
the subcutaneous route of exposure, virus dose was
prepared in a 10 μL volume in EMEM. Mice were in-
oculated in the left foot pad in order to track viral
replication in the surrounding tissue and draining
lymph node (popliteal lymph node). Control mice re-
ceived diluent only. Challenge virus preparations were
back-titrated by standard plaque assay using Vero
cells. Mice from the intranasal and aerosol studies
were euthanized at pre-determined time points: 6, 12,
24, 48, 72, 96, and 120 hours post-infection (hpi). In
addition to the previous listed time points, mice in
the subcutaneous study were also euthanized at 144,
168, and 192 hpi. At the time of euthanasia, mice
were anesthetized with mouse K-A-X (50 mg ketamine
(Fort Dodge Animal Health, Fort Dodge, IA), 0.5 mg ace-
promazine (Boehringer Ingelheim, Ridgefield, CT), and
5.5 mg xylazine (Lloyd Laboratories, Walnut, CA) givenintraperitoneal at a dose of 0.2 ml per 20 gm. There were
10 mice total for each time point, five mice from each
time point were euthanized and perfused with saline and
tissues were harvested for virus titer analysis and the other
five mice from each time point were euthanized and
perfused with 10 % neutral buffered formalin (NBF)
(LabChem, Inc., Pittsburg, PA) and tissues were har-
vested for histopathologic analysis.
Pathology
Animal tissues collected for pathology were fixed in
10 % NBF for a minimum of 21 days prior to removal
from the BSL-3 containment lab for processing. Skulls
were decalcified in 10 % EDTA in Tris buffer solution
(pH 6.95) (Sigma Chemical Co., St. Louis, MO). Tissues
were trimmed and processed according to standard
protocol and embedded in paraffin blocks. Histologic
sections were trimmed at 5–6 μm thickness, mounted
on positively charged glass slides (Superfrost Plus,
Fischer Scientific, Pittsburg, PA), and stained with
hematoxylin and eosin (PolyScientific, Bay Shore, NY).
Serial sections were stained for viral antigen using a
polyclonal rabbit antiserum directed against several
alphaviruses, followed by a horseradish peroxidase-labeled
polymer conjugated to goat anti-rabbit immunoglobulins.
Briefly, tissue sections were deparaffinized using Xyless
(LabChem, Inc.) and rehydrated using sequentially
less concentrated alcohol solutions ranging from
100 % to 70 %. Endogenous peroxidases were blocked
using a methanol/hydrogen peroxide solution. To in-
crease staining intensity, antigen retrieval was per-
formed by immersing slides in Tris/EDTA buffer for
30 min at 97 °C. Endogenous proteins were blocked
by incubating the slides in serum-free protein block
(Invitrogen, Carlsbad, CA) plus 5 % normal goat
serum (Vector Labs, Burlingame, CA) for 30 min at
room temperature. Sections were incubated with the
primary antibody, a polyclonal rabbit antiserum di-
rected against EEEV, WEEV, VEEV and Sindbis virus
(Applied Diagnostic Branch, Diagnostic Systems Div-
ision, USAMRIID) diluted 1:8000, for 30 min at room
temperature. Sections were then incubated with a sec-
ondary antibody, horseradish peroxidase-labeled poly-
mer conjugated to goat anti-rabbit immunoglobulins
(DAKO, Carpenteria, CA), and incubated for 30 min
at room temperature. Staining was completed by adding the
substrate-chromagen, diaminobenzidine (DAB) (DAKO)
and incubating slides for 5 min at room temperature.
Tissues were counterstained with hematoxylin for 2 min
at room temperature and then dehydrated in sequentially
more concentrated alcohol solutions, cleared using Xyless
II, and coverslip was mounted using Permount (Fisher
Scientific). Non-immune (normal) rabbit serum (Vector
Labs) was used as a negative control for the primary
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brain were used as a positive control.
Serial sections were stained for cleaved caspase-3, a
marker for apoptosis, using a monoclonal rabbit anti-
serum, followed by a horseradish peroxidase-labeled
polymer conjugated to goat anti-rabbit immunoglobu-
lins. Briefly, tissue sections were processed as described
above. Sections were then incubated with the primary
antibody, a monoclonal rabbit antiserum directed against
cleaved caspase-3 (Asp175) (51AE) (Cell Signaling Tech-
nology, Danvers, MA) diluted 1:100, for 60 min at room
temperature. Sections were then incubated with a second-
ary antibody, horseradish peroxidase-labeled polymer con-
jugated to goat anti-rabbit immunoglobulins (DAKO), and
incubated for 30 min at room temperature. Staining was
completed by adding the substrate-chromagen, diamino-
benzidine (DAB) (DAKO) and incubating slides for 5 min
at room temperature. Tissues were counterstained with
hematoxylin for 2 min at room temperature and then
dehydrated in sequentially more concentrated alcohol
solutions, cleared using Xyless II, and coverslip was
mounted using Permount. Non-immune (normal) rabbit
serum (Vector Labs) was used as a negative control for
the primary antibody. Sections of confirmed VEE virus-
infected mouse spleen were used as a positive control.
Serial sections were also stained for LC3B II, a marker
of autophagy, using a monoclonal rabbit antiserum,
followed by a horseradish peroxidase-labeled polymer
conjugated to goat anti-rabbit immunoglobulins. Briefly,
tissue sections were processed as described above. Sec-
tions were then incubated with the primary antibody, a
monoclonal rabbit antiserum directed against LC3B
(DII) x P (R) (Cell Signaling) diluted 1:500, for 60 min at
room temperature. Sections were then incubated with a
secondary antibody, horseradish peroxidase-labeled poly-
mer conjugated to goat anti-rabbit immunoglobulins
(DAKO), and incubated for 30 min at room temperature.
Staining was completed by adding the substrate-
chromagen, diaminobenzidine (DAB) (DAKO) and incu-
bating slides for 5 min at room temperature. Tissues were
counterstained with hematoxylin for 2 min at room
temperature and then dehydrated in sequentially more
concentrated alcohol solutions, cleared using Xyless II,
and coverslip was mounted using Permount. Non-
immune (normal) rabbit serum (Vector Labs) was used as
a negative control for the primary antibody.
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